A new observational study published in JAMA Network Open suggests that GLP-1 medications like Ozempic and Mounjaro may significantly reduce the risk of fragility fractures in people with type 2 diabetes, with the largest reductions seen in hip, femur, and spine fractures.

Plain English

These popular weight-loss and diabetes drugs might also be protecting bones. The study found patients taking GLP-1 drugs had fewer breaks from minor falls—a big deal because diabetes...